Literature DB >> 7582679

Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge Project for Later Life.

C Brayne1, C Gill, F A Huppert, C Barkley, E Gehlhaar, D M Girling, D W O'Connor, E S Paykel.   

Abstract

BACKGROUND: In developed countries, most dementia appears to be due to Alzheimer's disease and vascular dementia. We report rates for incidence of subtypes of dementia based on clinical diagnosis.
METHOD: This study was a 2.4-year (s.d. 2.6 months) follow-up of a cohort aged 75 years and over, seen initially in a prevalence study of dementia. A screening interview in 1173 survivors was followed in a subsample of 461 respondents by a diagnostic interview 1.8 months after screening (s.d. 1.5 months). This comprised a standardised interview with respondent and informant, with venepuncture where possible. Clinical diagnoses of subtypes were made by specified criteria.
RESULTS: The incidence of Alzheimer's disease of mild and greater severity was 2.7/1000 person-years at risk (1.6-4.4); in men 1.5 (0.8-2.7) and in women 3.3 (1.8-5.9). The incidence of vascular dementia was 1.2/100 person-years at risk (0.7-1.9); in men 1.1 (0.4-2.8) and in women 1.2 (0.7-2.0). Alzheimer's disease, but not vascular dementia, showed a marked increase with age, particularly in women. Rates for minimal dementia of different subtypes showed similar age and sex effects, but were much higher for Alzheimer's disease than vascular dementia.
CONCLUSIONS: The striking rise in incidence rates of dementia in the very old appear to be due to Alzheimer's disease, while rates for vascular dementia remain relatively constant. These trends are particularly marked for minimal dementia, but emphasise the importance of Alzheimer's disease in the community as a cause of cognitive decline of all degrees.

Entities:  

Mesh:

Year:  1995        PMID: 7582679     DOI: 10.1192/bjp.167.2.255

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  26 in total

1.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease.

Authors:  E B Mukaetova-Ladinska; F Garcia-Siera; J Hurt; H J Gertz; J H Xuereb; R Hills; C Brayne; F A Huppert; E S Paykel; M McGee; R Jakes; W G Honer; C R Harrington; C M Wischik
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Cerebral blood flow by arterial spin labeling in poststroke dementia.

Authors:  M J Firbank; J He; A M Blamire; B Singh; P Danson; R N Kalaria; J T O'Brien
Journal:  Neurology       Date:  2011-04-26       Impact factor: 9.910

Review 3.  Cognitive aging and Alzheimer's disease.

Authors:  R Vandenberghe; J Tournoy
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

Review 4.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

Review 5.  Gender-specific differences in the central nervous system's response to anesthesia.

Authors:  Lana J Mawhinney; Davita Mabourakh; Michael C Lewis
Journal:  Transl Stroke Res       Date:  2012-11-29       Impact factor: 6.829

Review 6.  North of England evidence based guidelines development project: guideline for the primary care management of dementia.

Authors:  M Eccles; J Clarke; M Livingstone; N Freemantle; J Mason
Journal:  BMJ       Date:  1998-09-19

7.  Factors producing over-selectivity in older individuals.

Authors:  Michelle P Kelly; Geraldine Leader; Phil Reed
Journal:  Age (Dordr)       Date:  2016-05-31

Review 8.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

9.  Pathophysiology of vascular dementia.

Authors:  Francesco Iemolo; Giovanni Duro; Claudia Rizzo; Laura Castiglia; Vladimir Hachinski; Calogero Caruso
Journal:  Immun Ageing       Date:  2009-11-06       Impact factor: 6.400

10.  Age-specific incidence rates for dementia and Alzheimer disease in NIA-LOAD/NCRAD and EFIGA families: National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease (NIA-LOAD/NCRAD) and Estudio Familiar de Influencia Genetica en Alzheimer (EFIGA).

Authors:  Badri N Vardarajan; Kelley M Faber; Thomas D Bird; David A Bennett; Roger Rosenberg; Bradley F Boeve; Neill R Graff-Radford; Alison M Goate; Martin Farlow; Robert A Sweet; Rafael Lantigua; Martin Z Medrano; Ruth Ottman; Daniel J Schaid; Tatiana M Foroud; Richard Mayeux
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.